American Association for the Advancement of Science, Science Advances, 3(6), 2020
DOI: 10.1126/sciadv.aax5032
Export citation
Search in Google Scholar
Show less
Full text: Download
The dual-targeted immunogene therapy that inhibits PD-L1 and provides IL-2 can enhance the therapeutic efficacy of cancer vaccine.